JILL GEBERT: Open Payments
NPI 1093176505 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 27 payments from 9 companies in 2025. Trend: 2023 $23 · 2024 $154 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $262 |
| AOP Health US, LLC | 1 | $142 |
| Novartis Pharmaceuticals Corporation | 6 | $133 |
| Impulse Dynamics (USA) Inc. | 2 | $129 |
| Novo Nordisk Inc | 1 | $117 |
| United Therapeutics Corporation | 3 | $91 |
| PFIZER INC. | 2 | $47 |
| BridgeBio Pharma, Inc. | 1 | $22 |
| HEARTFLOW, INC. | 1 | $22 |
Products named: Rapiblyk, LEQVIO, Optimizer, Ozempic, Tyvaso, REPATHA, VYNDAQEL, Attruby.
Industry payments across PA — which companies pay providers there.
